FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nienke van der Stoep

Research Profile

Chemicals & Drugs

Genes & Molecular Sequences

Anatomy

Physiology

Disorders

Co-author Network

Publications

TOP 3
Koen D Quint; Jeanet A C ter Huurne; Jasper I van der Rhee; Nienke van der Stoep; Ron Wolterbeek; Wilma Bergman; Nelleke A Gruis; Nicole A Kukutsch
Melanocortin 1 receptor (MC1R) variants in high melanoma risk patients are associated with specific dermoscopic ABCD features.
Femme Harinck; Irma Kluijt; Ernst J Kuipers; Rogier A Oldenburg; Jan-Werner Poley; Rolf Sijmons; Nienke van der Stoep; Theo A M van Os; Anja Wagner; Cora M Aalfs; Paul Fockens; Marco J Bruno
Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas.
Rowida Almomani; Nienke van der Stoep; Egbert Bakker; Johan T den Dunnen; Martijn H Breuning; Ieke B Ginjaar
Rapid and cost effective detection of small mutations in the DMD gene by high resolution melting curve analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nienke van der Stoep (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Koen D Quint; Jeanet A C ter Huurne; Jasper I van der Rhee; Nienke van der Stoep; Ron Wolterbeek; Wilma Bergman; Nelleke A Gruis; Nicole A Kukutsch
Melanocortin 1 receptor (MC1R) variants in high melanoma risk patients are associated with specific dermoscopic ABCD features.
Acta dermato-venereologica 2012;92(6):587-92.
2012: Femme Harinck; Irma Kluijt; Ernst J Kuipers; Rogier A Oldenburg; Jan-Werner Poley; Rolf Sijmons; Nienke van der Stoep; Theo A M van Os; Anja Wagner; Cora M Aalfs; Paul Fockens; Marco J Bruno
Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas.
Journal of medical genetics 2012;49(6):362-5.
2009: Rowida Almomani; Nienke van der Stoep; Egbert Bakker; Johan T den Dunnen; Martijn H Breuning; Ieke B Ginjaar
Rapid and cost effective detection of small mutations in the DMD gene by high resolution melting curve analysis.
Neuromuscular disorders : NMD 2009;19(6):383-90.
2009: Nienke van der Stoep; Chantal D M van Paridon; Tom Janssens; Petra Krenkova; Alexandra Stambergova; Milan Macek Jr.; Gert Matthijs; Egbert Bakker
Diagnostic guidelines for high-resolution melting curve (HRM) analysis: an interlaboratory validation of BRCA1 mutation scanning using the 96-well LightScanner.
Human mutation 2009;30(6):899-909.
2007: Nienke van der Stoep; Edwin Quinten; Gabrielle Alblas; Aurelie Plancke; Marja C J A van Eggermond; Tjadine M Holling; Peter J van den Elsen
Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.
Molecular immunology 2007;44(8):2036-46.
2004: Nienke van der Stoep; Edwin Quinten; Marisa Marcondes Rezende; Peter J van den Elsen
E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII).
Blood 2004;104(9):2849-57.
2004: Tjadine M Holling; Nienke van der Stoep; Peter J van den Elsen
Epigenetic control of CIITA expression in leukemic T cells.
Biochemical pharmacology 2004;68(6):1209-13.
2004: Peter J van den Elsen; Tjadine M Holling; Hedwich F Kuipers; Nienke van der Stoep
Transcriptional regulation of antigen presentation.
Current opinion in immunology 2004;16(1):67-75.
2003: Peter J van den Elsen; Tjadine M Holling; Nienke van der Stoep; Jeremy M Boss
DNA methylation and expression of major histocompatibility complex class I and class II transactivator genes in human developmental tumor cells and in T cell malignancies.
Clinical immunology (Orlando, Fla.) 2003;109(1):46-52.
2003: Peter J van den Elsen; Nienke van der Stoep
Class II transactivator (CIITA) deficiency in tumor cells: complicated mechanisms or not?
The American journal of pathology 2003;163(1):373-5; author reply 375-6.
2002: Nienke van der Stoep; Edwin Quinten; Peter J van den Elsen
Transcriptional regulation of the MHC class II trans-activator (CIITA) promoter III: identification of a novel regulatory region in the 5'-untranslated region and an important role for cAMP-responsive element binding protein 1 and activating transcription factor-1 in CIITA-promoter III transcriptional activation in B lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(9):5061-71.
2002: Nienke van der Stoep; Paula J Biesta; Edwin Quinten; Peter J van den Elsen
Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines.
International journal of cancer. Journal international du cancer 2002;97(4):501-7.
2002: Tjadine M Holling; Nienke van der Stoep; Edwin Quinten; Peter J van den Elsen
Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(2):763-70.
2001: Peter J van den Elsen; Sam J P Gobin; Nienke van der Stoep; Gert Datema; HE Viëtor
Transcriptional control of MHC genes in fetal trophoblast cells.
Journal of reproductive immunology 2001;52(1-2):129-45.
2000: Peter J van den Elsen; Nienke van der Stoep; HE Viëtor; L Wilson; M van Zutphen; Sam J P Gobin
Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA.
Human immunology 2000;61(9):850-62.